Experience
Representative Work
Cross-Border M&A; Greenfield Projects; Joint Ventures and Other Strategic Investments
- Represented LANXESS in the sale of its Urethane Systems business in the U.S. — as part of a global divestiture — to UBE Corporation of Japan.
- Represented The Coca-Cola Company (NYSE: KO) in the sale of its bottling businesses for still beverages in Mainland China to Swire Group and China Oil and Foodstuffs Corporation
- Represented Visirna, a subsidiary of Arrowhead Pharmaceuticals, in the sale of its Greater China rights to Plozasiran, a hypertriglyceridemia therapy, to Sanofi.
- Represented Guangzhou R&F Properties in the disposal of its equity interest in Guangzhou International Airport R&F Integrated Logistics Park — valued at approximately RMB 7.3 billion (US$1.14 billion) — to Blackstone
- Represented one of the world's largest EV battery components companies in its US$1 billion investment to establish a new EV battery component manufacturing facility in the U.S.
- Represented one of the world's largest solar panel companies in its US$200 million+ investment to establish a new solar panel assembly facility in the U.S.
- Represented H.J. Baker Sulphur Holdings, LLC in its acquisition and financing of Oxbow Sulphur Inc. and its worldwide sulphur business affiliates.
- Represented Eddingpharm Group, a leading pharmaceutical contract sales company in China, in its acquisition of certain pharmaceutical product rights in China from Eli Lilly.
- Represented Yili Group, the largest dairy products company in Asia, in its bidding for Stonyfield, the No. 1 organic yogurt maker in the U.S. and a subsidiary of Danone.
- Represented a U.S. maritime technology company in its sale to a Beijing-based Chinese public company.
- Represented certain shareholders of a Minnesota-based private marketing and sales company in the proposed sale of their controlling interests to a Chinese public company.
- Represented CDH Investments, a leading Chinese private equity firm, in multiple acquisitions and investments.
- Represented a Hong Kong Stock Exchange-listed real estate conglomerate in its acquisitions of multiple real estate portfolios in the U.S., including retirement living facilities, student housing projects, and other commercial and mixed-use properties.
- Represented a leading non-profit biomedical research organization in the U.S. in connection with its proposed joint venture and collaborative research initiatives with business partners and universities in China.
- Represented WinIt America in its investments in, and establishment of, multiple warehouse and logistics facilities in New Jersey, Kentucky, Texas, Arizona, and Georgia.
- Represented a New York-based IVF clinic center in its separation of non-clinical assets and receipt of investments from international investors.
- Represented a restaurant chain in its group reorganization, business expansion, franchising, and other corporate matters.
- Represented Fantasia Group, China's largest property management conglomerate, in its expansion and operations in the U.S.
- Represented multiple pharmaceutical, biotech, clean energy, and technology companies in debt and equity financings, including SAFE agreements, Series Seed, convertible notes, and Series A, B, and C rounds.
Life Sciences Licensing and Commercial Contracts
- Represented a leading global biopharmaceutical company in negotiating a mutual licensing agreement with a leading U.S. biotechnology company for two bifunctional sialidase programs.
- Represented multiple U.S. biotech companies in negotiating out-licensing agreements with Asian licensees for vaccine technologies and products.
- Represented a leading Chinese pharmaceutical company in negotiating an in-licensing agreement with a U.S. company for technologies and products to treat breast cancer.
- Represented a leading Chinese pharmaceutical company in negotiating an in-licensing agreement with a Belgian company for technologies and products to treat diabetic macular edema.
- Represented a leading Chinese specialty pharmaceutical company in negotiating an in-licensing agreement with a diversified biopharmaceutical company for technologies and products to treat chronic obstructive pulmonary disease.
- Represented a leading Chinese pharmaceutical company in negotiating an in-licensing agreement and supply agreement with a leading biopharmaceutical company for technologies and products to treat neonatal respiratory disease.
- Represented a U.S. startup in negotiating an in-licensing agreement with a Japanese biopharmaceutical company for technologies and products to treat certain cancers.
- Represented a Chinese dental startup in negotiating an in-licensing agreement for clear aligner technology with a U.S. company.
- Represented multiple biotech and pharmaceutical companies in negotiating supply agreements and distribution agreements.
- Represented U.S. distributors and Chinese suppliers in negotiating manufacturing and supply arrangements for industrial and consumer products.
General Corporate — Structuring, Formation, and Governance
- Advised a major publicly traded Chinese pharmaceutical company and its U.S. subsidiaries on their corporate and commercial ventures.
- Represented a connected vehicle software and hardware developer in business structuring and general corporate matters.
- Represented a leading 3D printing company in its business restructuring across the U.S., the EU, and Asia.
- Represented a carbon capture company in its expansion in the U.S.
- Represented multiple restaurant chains in business structuring, general corporate, employment, intellectual property, and other matters.
- Counseled Ninebot Limited, a portfolio company of Xiaomi Technologies and Sequoia Capital, in general corporate, employment, intellectual property, and other matters.
- Represented multiple biotech companies based in California, Massachusetts, and New Jersey in matters relating to their U.S. operations and cross-border commercial contracts.
- Represented a leading baby product company in matters relating to corporate structuring, governance, employment, intellectual property, compliance, and legal risk management.
- Represented one of the largest dairy products companies in China in its expansion in the U.S.
- Represented a leading infrastructure construction company in China in its expansion in the U.S.
Private Equity Fund Formation and Investments
- Represented a sponsor group in the organization of a private equity fund focused on restaurant investments.
- Represented a sponsor group in the organization of a private equity fund focused on AI data center investments.
- Represented a sponsor group in the organization of a US$150 million private equity fund.
- Represented an investment fund in secondary transactions acquiring over US$500 million of limited partner commitments.
- Represented a Chinese state-owned asset management company — with assets under management exceeding RMB one trillion yuan — in its investment in a US$650 million private debt fund.
- Represented a private equity fund with US$250 million in assets under management in its reorganization.
- Represented a family office in its investments in multiple single-investment SPV funds organized to invest in China-based pre-IPO, growth-stage companies.
Regulatory Compliance: CFIUS, Export Controls, Sanctions, and FEOC/PFE
- Represented one of the world's largest solar panel companies in CFIUS analysis related to its business expansion in the U.S.
- Represented a leading power transmission product company in CFIUS analysis related to its business expansion in the U.S.
- Represented a leading cleantech company in CFIUS analysis related to its business expansion in the U.S.
- Represented a leading 3D printer company in CFIUS analysis related to its business reorganization.
- Represented a leading software and hardware supplier for connected vehicles in complying with the Commerce Department's connected vehicle rules
- Represented a leading recruitment and job-hunting company in CFIUS and export control analysis related to its business structuring and expansion in the U.S.
- Represented multiple venture capital funds and their portfolio companies in transaction-based CFIUS analysis and post-closing CFIUS compliance efforts.
- Represented one of the world’s largest payment card networks in its CFIUS analysis, compliance program, and training.
- Represented multiple clean energy and power equipment companies in foreign entity of concern (FEOC) and prohibited foreign entity (PFE) analysis under the One Big Beautiful Bill Act (OBBBA).
- Represented a leading Chinese textile manufacturer and exporter in response to U.S. sanctions and U.S. Customs and Border Protection (CBP) actions relating to alleged use of forced labor in the Xinjiang Uyghur Autonomous Region of China.
- Represented a Chinese financial institution in connection with semiconductor product and equipment restrictions and foreign direct product rules under the October 7, 2022 export control rules.
Product Liability, CPSC, and CBP Compliance
- Represented a Chinese home appliance manufacturer in managing its product recall in the U.S. and Canada, including negotiating with its U.S. distributor on allocation of recall liabilities, preparing responses to the Consumer Product Safety Commission (CPSC), implementing the recall plan, and coordinating with insurance carriers.
- Represented a leading electrical transformer manufacturer in managing a U.S. product recall, including negotiating with distributors and energy companies and implementing the recall plan.
- Represented a furniture importer in protesting CBP’s AD/CVD decisions.
- Represented multiple U.S. importers in seeking refunds of tariffs imposed under the International Emergency Economic Powers Act (IEEPA).
- Represented a furniture distributor in managing its product recall in the U.S.
- Represented a baby product manufacturer in addressing a CPSC inquiry, successfully mitigating the risk of a product recall.
- Represented multiple furniture importers in response to CBP and CPSC enforcement actions.
- Represented a Chinese consumer product manufacturer in managing a potential product recall in the U.S.
- Represented multiple Chinese manufacturers in handling product liability matters in the U.S., including engaging and coordinating adjusters and negotiating settlement agreements with claimants.
Dispute Resolutions
- Represented a Chinese consumer product manufacturer in defending against a customer's lawsuit asserting fraud and tortious interference claims.
- Represented minority shareholders in protecting their rights and economic stakes in several controlling-shareholder-dominated situations.
- Represented multiple Chinese companies in handling disputes with U.S. distributors and customers.

